Antitrust Antitrust

Teva files CREATES Act suit in US, accusing Amicus Therapeautics of blocking Galafold sample access

By Max Fillion
  • 13 Jul 2021 19:06
  • 13 Jul 2021 20:22
Teva Pharmaceuticals filed a lawsuit under the newly minted CREATES Act in a Pennsylvania federal court today. The Israeli drug giant accused Amicus Pharmaceuticals of denying access to samples of Galafold, a Fabry disease treatment.

The Creating and Restoring Equal Access to Equivalent Samples Act was signed into law by former

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News